William Blair downgrades Neogen stock to Market Perform on weak outlook

Published 29/07/2025, 21:10
William Blair downgrades Neogen stock to Market Perform on weak outlook

Investing.com - William Blair downgraded Neogen (NASDAQ:NEOG) from Outperform to Market Perform on Tuesday, citing concerns about the company’s growth prospects amid challenging macroeconomic conditions. The stock, currently trading at $4.83, has experienced significant volatility, falling over 50% in the past six months. According to InvestingPro analysis, Neogen appears undervalued at current levels.

The downgrade follows Neogen’s fiscal fourth-quarter update, which included fiscal 2026 revenue guidance suggesting flat to declining revenues when excluding the company’s recently divested disinfectant business.

William Blair noted that one of its core bullish arguments for Neogen had been the potential for profitability growth as increasing volumes would deliver high incremental margins, but this thesis has been challenged by the worsening macro environment.

The research firm expressed concern about several factors that could continue to pressure Neogen’s markets, including recent upticks in food CPI, cuts to SNAP benefits in the recent tax bill, and the current administration’s focus on reducing regulation and costs.

While acknowledging that Neogen operates in a historically macro-resilient market, William Blair indicated it is difficult to envision a scenario where macroeconomic conditions improve sufficiently to overcome these headwinds, leading to the firm’s more cautious stance on the stock.

In other recent news, Neogen Corporation reported its fourth-quarter 2025 earnings, delivering results that exceeded analysts’ expectations. The company posted an earnings per share (EPS) of $0.05, outperforming the forecasted -$0.03. Revenue figures also came in strong, reaching $225.5 million, which surpassed the anticipated $221.92 million. Despite these positive earnings and revenue results, Neogen’s stock experienced a decline in premarket trading. This suggests that investors may have concerns beyond the reported financial performance. These developments highlight the importance of closely monitoring Neogen’s future announcements and market reactions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.